GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Prostatype Genomics PROGEN.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.10

+1.93%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 594,000

FY2015FY2025

Net income

−SEK 44.5m

FY2015FY2025

Free cash flow

−SEK 24.1m

FY2015FY2025

Shareholders' equity

SEK 26.5m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015
RevenueSEK 594,000SEK 199,000SEK 1.4mSEK 683,000SEK 10,000SEK 683,878SEK 74,085SEK 161,843SEK 5.0mSEK 101,500
Research and developmentSEK 1.5mSEK 2.2mSEK 3.2mSEK 3.5mSEK 1.5mSEK 2.4mSEK 1.2mSEK 2.5mSEK 2.1mSEK 2.2m
Operating income−SEK 39.1m−SEK 40.9m−SEK 39.2m−SEK 28.7m−SEK 15.5m−SEK 16.6m−SEK 7.9m−SEK 9.2m−SEK 4.6m−SEK 11.4m
Net income−SEK 44.5m−SEK 41.1m−SEK 41.4m−SEK 29.1m−SEK 15.6m−SEK 17.4m−SEK 8.5m−SEK 9.3m−SEK 4.7m−SEK 11.5m
Diluted earnings per share-0.88-18.76-388.70-12.82-9.97-1.55-0.14-0.16-0.08-0.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015
Total assetsSEK 50.9mSEK 42.0mSEK 49.2mSEK 30.9mSEK 40.2mSEK 33.7mSEK 17.6mSEK 19.7mSEK 19.7mSEK 4.1m
Cash and short-term investmentsSEK 9.1mSEK 9.4mSEK 2.7mSEK 11.5mSEK 20.3mSEK 15.9mSEK 2.7mSEK 8.2mSEK 10.5mSEK 2.6m
Total liabilitiesSEK 24.3mSEK 8.5mSEK 24.5mSEK 4.8mSEK 4.3mSEK 5.4mSEK 9.0mSEK 13.5mSEK 4.8mSEK 5.5m
DebtSEK 5.3mSEK 67,000SEK 11.7mSEK 867,000SEK 1.3mSEK 1.5mSEK 6.9mSEK 9.6mSEK 2.1mSEK 3.9m
Shareholders' equitySEK 26.5mSEK 33.5mSEK 24.7mSEK 26.2mSEK 35.9mSEK 28.3mSEK 8.5mSEK 6.2mSEK 14.9m−SEK 1.3m
Shares outstanding51m2m0m2m2m11m59m59m59m—

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2016FY2015
Cash from operations−SEK 23.8m−SEK 44.7m−SEK 29.1m−SEK 27.7m−SEK 16.1m−SEK 14.7m−SEK 9.6m−SEK 5.7m−SEK 9.6m—
Capital spending−SEK 258,000−SEK 7.9m−SEK 8.6m−SEK 2−SEK 2.5m−SEK 26,199−SEK 3.3m−SEK 4.7m−SEK 26,995—
Free cash flow−SEK 24.1m−SEK 52.6m−SEK 37.7m−SEK 27.7m−SEK 18.6m−SEK 14.7m−SEK 12.9m−SEK 10.4m−SEK 9.7m—

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 333,000SEK 333,000SEK 174,000SEK 174,000SEK 123,000SEK 123,000SEK 235,000SEK 235,000
Operating income−SEK 9.3m−SEK 9.3m−SEK 9.4m−SEK 9.4m−SEK 10.0m−SEK 10.0m−SEK 10.7m−SEK 10.7m
Net income−SEK 8.7m−SEK 8.7m−SEK 10.3m−SEK 10.3m−SEK 12.0m−SEK 12.0m−SEK 10.7m−SEK 10.7m
Diluted earnings per share-0.15-0.15-0.20-0.20-0.24-0.24-4.89-4.89
Cash from operations−SEK 7.0m−SEK 7.0m−SEK 3.0m−SEK 3.0m−SEK 8.0m−SEK 8.0m−SEK 10.0m−SEK 10.0m
Total assetsSEK 39.9mSEK 39.9mSEK 50.9mSEK 50.9mSEK 43.8mSEK 43.8mSEK 42.0mSEK 42.0m
Cash and short-term investmentsSEK 392,000SEK 392,000SEK 9.1mSEK 9.1mSEK 12.9mSEK 12.9mSEK 9.4mSEK 9.4m
Debt——SEK 5.3mSEK 5.3m——SEK 67,000SEK 67,000
Shareholders' equitySEK 6.5mSEK 6.5mSEK 26.5mSEK 26.5mSEK 36.5mSEK 36.5mSEK 33.5mSEK 33.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-4.5%-2.8%19.3%
Operating income10.9%18.7%13.1%
Net income15.2%20.6%14.5%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-10079.8%-5221.4%-5106.2%—
Net margin-10788.7%-5511.2%-5363.6%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-0.2-0.1—-0.0-0.2-2.2
Price to sales14.010.80.11.7335.356.3

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 1000-to-1 reverse split · 31 Oct 2024

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.